Management of Potential Long-Term Toxicities in Breast Cancer Patients

Curr Breast Cancer Rep. 2016 Dec;8(4):183-192. doi: 10.1007/s12609-016-0229-0. Epub 2016 Oct 13.

Abstract

Breast cancer is the most common non-cutaneous malignancy among women, and there are over 3 million breast cancer survivors living in the United States today. Excellent cure rates with modern therapies are associated with substantial toxicities for many women; it is important that health care providers attend to the resulting symptoms and issues to optimize quality of life in this population. In this article, we review management options for potential long term toxicities in breast cancer survivors, with a particular focus on bone health, fertility preservation, premature menopause, cardiac dysfunction, and cognitive impairment.

Keywords: breast cancer; breast neoplasm; cardiomyopathy; cognitive function; fertility; menopause; osteoporosis; potential long term toxicities; quality of life; review.; toxicities.